View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Tables: April 27, 2019

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

XNCR XENCOR INC.
RYI RYERSON HOLDING CORPORATION
PJT PLURISTEM THERAPEUTICS INC.
MHLD MAIDEN HOLDINGS LTD.
MACK MERRIMACK PHARMACEUTICALS INC
LTS LADENBURG THALMANN FINANCIAL SERVICES INC.
LNDC LANDEC CORP.
HIIQ HEALTH INSURANCE INNOVATIONS INC
GTE GRAN TIERRA ENERGY
GABC GERMAN AMERICAN BANCORP
FB FACEBOOK INC. CLASS A
EQT EQT CORPORATION
DNR DENBURY RESOURCES INC.
BSRR SIERRA BANCORP
VPA1 AVEO PHARMACEUTICALS INC.
AR ANTERO RESOURCES CORPORATION
ALSN ALLISON TRANSMISSION HOLDINGS INC.
AGRX AGILE THERAPEUTICS
AEL AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY
OASPQ OASIS PETROLEUM INC.
GRBK GREEN BRICK PARTNERS
IIIN INSTEEL INDUSTRIES INC.
KNDI KANDI TECHNOLGIES GROUP (N SHARES)
CCI CROWN CASTLE INTERNATIONAL CORP
CECE CECO ENVIRONMENTAL CORP.
HOFT HOOKER FURNITURE CORP.
KMI KINDER MORGAN INC CLASS P
UNT UNIT CORPORATION
HIX WESTERN ASSET HIGH INCOME FUND II
EHI WESTERN ASSET GLOBAL HIGH INCOME FUND
LONEQ LONESTAR RESOURCES
HIO WESTERN ASSET HIGH INCOME OPPORTUNITY FUND
INSG INSEEGO CORP
VBTX VERITEX HOLDINGS INC.
SNAP SNAP INC. CLASS A
VVR INVESCO SENIOR INCOME TRUST
CMP COMPA SA
MBIN MERCHANTS BANCORP
WGO WINNEBAGO INDUSTRIES INC.
ZSAN ZOSANO PHARMA CORP
RMBL RUMBLEON INC
MYOS ATLAS THERAPEUTICS CORP
WSC WILLSCOT MOBILE MINI HOLDINGS CORP. CLASS A
OPNT OPIANT PHARMACEUTICALS
CTXR CITIUS PHARMACEUTICALS
FIXX HOMOLOGY MEDICINES
FUND ROYCE FOCUS TRUST
ANIX INC.
NHS ANIXA BIOSCIENCES
ETRN NEUBERGER BERMAN HIGH YIELD ST
CHAP EQUITRANS MIDSTREAM CORP
ELGX CHAPARRAL ENERGY
PRSP INC.
DARE ENDOLOGIX INC.
TST PROSPERITY BANCSHARES
KFS INC.
DARE BIOSCIENCE
INC.
THESTREET
KINGSWAY FINANCIAL SERVICES
Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: April 18, 2019

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

1 director bought

A director at Zosano Pharma Corp bought 100,000 shares at 3.500USD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch